×

Traders talk Barclays' bullish pharma call

The "Halftime Report" closed the show with their top trades on Barclays' bullish pharmaceutical call. Barclays assumed coverage of Eli Lilly, Johnson & Johnson, and Merck at overweight.

Pete Najarian likes the pharma and biotech sector.

Steve Weiss feels you must be selective. Weiss added drug stocks may be under pressure during the Presidential election.

Trader disclosure: On December 1, 2015, the following stocks and commodities mentioned or intended to be mentioned on CNBC's "Fast Money" were owned by the "Halftime Report" traders:

PETE NAJARIAN: Long AAPL, AMAT, BAC, BMY, BP, CSX, DIS, DISCA, DKS, FOXA, GE, KKR, KO, MRK, PEP, PFE, PHM he is long calls A, ABX, BAC, BEE, DDD, DOW, EMR, FITB, GLW, LC, MOS, MRK, MSFT, PBR, POT, UA, UAL, VZ, XLF, ZIOP He is long puts FCX, MRO, X

JON NAJARIAN: Long PPG, SCTY he is long calls APA, AAPL, AVGO, BAX, CMCSA, DAL, DOW, ECA, EEM, GPRO, JAH, JBLU, KHC, LUV, MCK, MDLZ, MOS, MSFT, MU, NVDA, OAS, P, PPG, PXD, RLL, SCTY, TSM, XLNX, ZOIP

JOE TERRANOVA: Long VRTS

STEVE WEISS: Long AAL, AKAM, C, DLTR, MU, VIA